Alembic Pharmaceuticals Limited — Others, 04-04-2025: Certificate under SEBI (Depositories and Participants) Regulations, 2018

Alembic Pharmaceuticals has shared a certificate confirming compliance with SEBI regulations for the quarter ended 31st March 2025. The Registrar and Share Transfer Agent, MUFG Intime India, affirmed that all securities received for dematerialization were processed, and relevant securities are properly listed on stock exchanges. This update reinforces the company's operational efficiency and adherence to guidelines, which may enhance investor confidence. The smooth handling of securities suggests a strong governance framework, creating a positive outlook for shareholder interests moving forward.